Cargando…

Silencing Antibiotic Resistance with Antisense Oligonucleotides

Antisense technologies consist of the utilization of oligonucleotides or oligonucleotide analogs to interfere with undesirable biological processes, commonly through inhibition of expression of selected genes. This field holds a lot of promise for the treatment of a very diverse group of diseases in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jani, Saumya, Ramirez, Maria Soledad, Tolmasky, Marcelo E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068983/ https://www.ncbi.nlm.nih.gov/pubmed/33921367 http://dx.doi.org/10.3390/biomedicines9040416

Ejemplares similares

Antisense Oligonucleotide Activation via Enzymatic Antibiotic Resistance Mechanism
por: Darrah, Kristie E., et al.
Publicado: (2023)

In-silico study of antisense oligonucleotide antibiotics
por: Chen, Erica S., et al.
Publicado: (2023)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
por: Gagliardi, Maria, et al.
Publicado: (2021)

Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023)

Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
por: Sardone, Valentina, et al.
Publicado: (2017)

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement
por: Batista-Duharte, Alexander, et al.
Publicado: (2020)

Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes
por: Jackson, Alexis, et al.
Publicado: (2016)

A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells
por: Castanotto, Daniela, et al.
Publicado: (2015)

Hydrogen peroxide-triggered gene silencing in mammalian cells through boronated antisense oligonucleotides
por: Mori, Shohei, et al.
Publicado: (2017)

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
por: Korobeynikov, Vladislav A., et al.
Publicado: (2022)

Amikacin: Uses, Resistance, and Prospects for Inhibition
por: Ramirez, Maria S., et al.
Publicado: (2017)

Antisense Oligonucleotide-Based Therapy of Viral Infections
por: Tarn, Woan-Yuh, et al.
Publicado: (2021)

Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016)

Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022)

Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides
por: Goyenvalle, Aurélie, et al.
Publicado: (2023)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011)

Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells
por: Sousa de Almeida, Mauro, et al.
Publicado: (2022)

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
por: Stein, C. A., et al.
Publicado: (2010)

Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides
por: Kaniowski, Damian, et al.
Publicado: (2022)

Zinc: Multidimensional Effects on Living Organisms
por: Cuajungco, Math P., et al.
Publicado: (2021)

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
por: Ramirez, Maria Soledad, et al.
Publicado: (2020)

Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
por: Gagliardi, Maria, et al.
Publicado: (2022)

The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey
por: Agrawal, Sudhir
Publicado: (2021)

New treatments for myasthenia: a focus on antisense oligonucleotides
por: Angelini, Corrado, et al.
Publicado: (2013)

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
por: Dhuri, Karishma, et al.
Publicado: (2020)

Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
por: Giudice, Valentina, et al.
Publicado: (2020)

Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
por: Gareri, Clarice, et al.
Publicado: (2022)

Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii
por: Batista-Duharte, Alexander, et al.
Publicado: (2021)

Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
por: Lennox, Kim A., et al.
Publicado: (2016)

The use of nano-sized acicular material, sliding friction, and antisense DNA oligonucleotides to silence bacterial genes
por: Mitsudome, Yuya, et al.
Publicado: (2014)

Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts
por: Shin, Minwook, et al.
Publicado: (2022)

Small Klebsiella pneumoniae Plasmids: Neglected Contributors to Antibiotic Resistance
por: Ramirez, Maria S., et al.
Publicado: (2019)

The powerful world of antisense oligonucleotides: From bench to bedside
por: Quemener, Anaïs M., et al.
Publicado: (2020)

Antisense Gene Silencing: Therapy for Neurodegenerative Disorders?
por: Nielsen, Troels T., et al.
Publicado: (2013)

Identification of the Acinetobacter baumannii Ribonuclease P Catalytic Subunit: Cleavage of a Target mRNA in the Presence of an External Guide Sequence
por: Davies-Sala, Carol, et al.
Publicado: (2018)

Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4t1a3lg7bubeovj8p0iohs0it9